Quantitative short echo time (1) H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma
J. Wijnen, A. Idema, M. Stawicki, M. Lagemaat, P. Wesseling, A. Wright, T. Scheenen and A. HeerschapArticles
JMRI
2012
1072-1082
Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?
L. Heijmen, M. Verstappen, E. Ter Voert, C. Punt, W. Oyen, L. de Geus-Oei, J. Hermans, A. Heerschap and H. van LaarhovenArticles
CRIREVOH
2012
194--207
A phase and frequency alignment protocol for (1)H MRSI data of the prostate
A. Wright, L. Buydens and A. HeerschapArticles
NMRB
2012
755-765
Simple baseline correction for (1) H MRSI data of the prostate
A. Wright and A. HeerschapArticles
MRM
2012
1724-1730
31P MRSI and 1H MRS at 7 T: initial results in human breast cancer
D. Klomp, B. van de Bank, A. Raaijmakers, M. Korteweg, C. Possanzini, V. Boer, C. van de Berg, M. van de Bosch and P. LuijtenArticles
NMRB
2011
1337--1342
Detection of fully refocused polyamine spins in prostate cancer at 7T
D. Klomp, T. Scheenen, C. Arteaga, J. van Asten, V. Boer and P. LuijtenArticles
NMRB
2011
299--306
In Vivo Assessment of Prostate Cancer Aggressiveness Using Magnetic Resonance Spectroscopic Imaging at 3 T with an Endorectal Coil
T. Kobus, T. Hambrock, C. de Hulsbergen-van Kaa, A. Wright, J. Barentsz, A. Heerschap and T. ScheenenArticles
EU
2011
1074--1080
Semi-LASER localized dynamic 31P magnetic resonance spectroscopy in exercising muscle at ultra-high magnetic field
M. Meyerspeer, T. Scheenen, A. Schmid, T. Mandl, E. Unger and E. MoserArticles
MRM
2011
1207--1215
Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models
A. Navis, B. Hamans, A. Claes, A. Heerschap, J. Jeuken, P. Wesseling and W. LeendersArticles
JPAT
2011
626--634
Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study
P. Nunes, J. Jones, A. Rolo, C. Palmeira and R. CarvalhoArticles
NMRB
2011
1145--1158
On the relevance of automatically selected single-voxel MRS and multimodal MRI and MRSI features for brain tumour differentiation
G. Postma, J. Luts, A. Idema, M. Julia-Sapé, A. Moreno-Torres, W. Gajewicz, J. Suykens, A. Heerschap, S. Huffel and L. BuydensArticles
CBM
2011
87--97
Exploiting spatial information to estimate metabolite levels in two-dimensional MRSI of heterogeneous brain lesions
A. Sava, D. Sima, J. Poullet, A. Wright, A. Heerschap and S. HuffelArticles
NMRB
2011
824--835
Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation study
T. Scheenen, J. Fütterer, E. Weiland, P. van Hecke, M. Lemort, C. Zechmann, H. Schlemmer, D. Broome, G. Villeirs, J. Lu, J. Barentsz, S. Roell and A. HeerschapArticles
IR
2011
25--33
Discrimination between metastasis and glioblastoma multiforme based on morphometric analysis of MR images
L. Blanchet, P. Krooshof, G. Postma, A. Idema, B. Goraj, A. Heerschap and L. BuydensArticles
AJNR
2011
67--73
A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging
F. Bonetto, M. Srinivas, A. Heerschap, R. Mailliard, E. Ahrens, C. Figdor and I. de VriesArticles
IJC
2011
365--373
Overview on the use of NMR to examine protein structure
V. Breukels, A. Konijnenberg, S. Nabuurs, J. Doreleijers, N. Kovalevskaya and G. VuisterArticles
Curr Protoc Protein Sci
2011
Unit17.5
The second Ca(2+)-binding domain of NCX1 binds Mg2+ with high affinity
V. Breukels, A. Konijnenberg, S. Nabuurs, W. Touw and G. VuisterArticles
Biochemistry
2011
8804--8812